Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) had its price target upped by investment analysts at Citigroup from $4.00 to $5.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target would indicate a potential upside of 79.53% from the company’s […]

e.l.f. Beauty (NYSE:ELF – Get Free Report) had its price objective upped by equities researchers at Bank of America from $100.00 to $118.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price objective indicates a potential upside of 22.13% from the stock’s […]

Benitec Biopharma (NASDAQ:BNTC – Get Free Report) had its price objective hoisted by analysts at Wedbush from $16.00 to $17.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Wedbush’s price objective suggests a potential upside of 41.42% from the company’s […]